Controllable biodegradability, drug release behavior and hemocompatibility of PTX-eluting magnesium stents

Colloids and Surfaces B: Biointerfaces

Volumn 83, Issue 1, 2011, Pages 23-28

  Lu, Ping ^a   Fan, Hainan ^a   Liu, Yin ^b   Cao, Lu ^b   Wu, Xiangfeng ^a   Xu, Xinhua ^a  

^a TIANJIN UNIVERSITY   (China)

^b TIANJIN CHEST HOSPITAL   (China)

Author keywords

Anticorrosion; Drug release; Magnesium; MAO; PTX; Stent

Indexed keywords

ANTI-CORROSION; DRUG RELEASE; MAO; PTX; STENT;

COMPOSITE COATINGS; CORROSION PROTECTION; CORROSION RESISTANCE; DEGRADATION; LACTIC ACID; MAGNESIUM; MAGNESIUM ALLOYS; MICROBIOLOGY; SCANNING ELECTRON MICROSCOPY; STAINLESS STEEL;

BIODEGRADATION;

MAGNESIUM; PACLITAXEL; POLYGLACTIN; POLYLACTIC ACID;

ARTICLE; BIODEGRADABILITY; BLOOD COMPATIBILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG COATING; DRUG ELUTING STENT; EQUIPMENT DESIGN; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TEMPERATURE; MOLECULAR WEIGHT; NANOFABRICATION; OXIDATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; SUSTAINED RELEASE PREPARATION; THROMBOCYTE ADHESION; ULTRAVIOLET SPECTROPHOTOMETRY;

BIODEGRADATION, ENVIRONMENTAL; CALORIMETRY, DIFFERENTIAL SCANNING; COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; HUMANS; LACTIC ACID; MAGNESIUM; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR WEIGHT; PACLITAXEL; PLATELET ADHESIVENESS; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; SURFACE PROPERTIES;

EID: 78650193190     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.10.038     Document Type: Article

References (24)

1. Heublein B., Rohde R., Kaese V., et al. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?. Heart 2003, 89:651-656.
2. Erne P., Schier M., Resink T.J. The road to bioabsorbable stents: reaching clinical reality?. Cardiovasc. Intervent. Radiol. 2006, 29:11-16.
3. Shi P., Ng W.F., Wong M.H., Cheng F.T. Improvement of corrosion resistance of pure magnesium in Hank's solution by microarc oxidation with sol-gel TiO2 sealing. J. Alloy Compd. 2008, 469:286-292.
4. Wang H., Estrin Y. Bio-corrosion of a magnesium alloy with different processing histories. Mater. Lett. 2008, 62:2476-2479.
5. Waksman R., et al. Promise and challenges of bioabsorbable stents. Interv. Rounds 2007, 70:407-414.
6. Delva P. Magnesium and coronary heart disease. Mol. Aspects Med. 2003, 24:63-78.
7. Gawaz M., Ott I., Reininger A.J., Neumann F.J. Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelet in vitro and exvivo. Thromb. Haemost. 1994, 72:912-918.
8. Nadler J.L., Goodson S., Rude R.K. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 1987, 9:379-383.
9. Chiu K.Y., Wong M.H., Wong F.T., Wong H.C. Characterization and corrosion studies of fluoride conversion coating on degradable Mg implants. Surf. Coat. Technol. 2007, 202:590-598.
10. Li L.C., Li J.C., Li Y. Evaluation of cyto-toxicity and corrosion behavior of alkali-heat-treated magnesium in simulated body fluid. Surf. Coat. Technol. 2004, 185:92-98.
11. Liu C.L., Liu Y.C., Tian X.B., Tian P.K. Corrosion behavior of AZ91 magnesium alloy treated by plasma immersion ion implantation and deposition in artificial physiological fluids. Thin Solid Films 2007, 516:422-427.
12. Yerokhin A.L., Nie X., Leyland A., Mattews A., Dowey S.G. Plasma electrolysis for surface engineering. Surf. Coat. Technol. 1999, 122:73-93.
13. Rama Krishna L., Somajaju K.R.C., Sundararajan G. The tribological performance of ultra-hard ceramic composite coatings obtained through microarc oxidation. Surf. Coat. Technol. 2003, 163:484-490.
14. Yerokhin A.L., Leyland A., Matthews A. Kinetic aspects of aluminium titanate layer formation on titanium alloys by plasma electrolytic oxidation. Appl. Surf. Sci. 2002, 200:172-184.
15. Guo H.F., An M.Z., Huo H.B., Xu S., Wu L.J. Microstructure characteristic of ceramic coatings fabricated on magnesium alloys by micro-arc oxidation in alkaline silicate solutions. Appl. Surf. Sci. 2006, 252:7911-7916.
16. Acharya G., Park K. Stent coatings for drug delivery. Adv.Drug Deliv. Rev. 2006, 58:387-401.
17. Wang X.Y., Zhang X.H., Castellot J., Herman I., Iafrati M., Kaplan D.L. Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses. Biomaterials 2008, 29:894-903.
18. Alexis F., Venkatraman S.S., Rath S.K., Boey F. In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices. J. Control. Release 2004, 98:67-74.
19. Drachman D.E., Edelman E.R., Seifert P., et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J. Am. Coll. Cardiol. 2000, 36:2325-2332.
20. Erbel R., Waksman R., Heublein B., et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 2007, 369:1869-1875.
21. Waksman R., Horrigan M., Weissman N.J., Mario C.Di., et al. Early- and Long-Term Intravascular Ultrasound and Angiographic Findings After Bioabsorbable Magnesium Stent Implantation in Human Coronary Arteries. J. Am. Coll. Cardiol. Intv. 2009, 2:312-320.
22. Waksman R., Erbel R., Mario C.Di., et al. Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. Eurointervention 2009, 4:481-484.
23. Mario C.Di., et al. AMSINSIGHT-absorbable metal stent implantation for treatment of below-theknee critical limb ischemia: 6-month analysis. Cardiovasc. Interv. Radiol. 2009, 2:424-435.
24. Erne P., Schier M., Resink T.J. The road to bioabsorbable stents: reaching clinical reality?. Cardiovasc. Interv. Radiol. 2006, 29:11-16.